HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
VEEV
Veeva Systems Inc.
VEEV's fundamentals are strong and it looks cheap: trading at 50x earnings, below its usual 64x. Analysts expect earnings growth.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
VEEV Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
VEEV's revenue, profitability, cash flow and balance sheet are all currently healthy.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
VEEV PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 30x | $302 | — |
| Current | 50x | $302 | — |
| Cheap | 53x | $324 | +7.1% |
| Fair | 64x | $389 | +29% |
| Expensive | 115x | $700 | +131% |
Historical ranges are pointers, not guarantees.
VEEV's PE is in its cheap range at 50x. If earnings grow as analysts expect, today's price would be 30x next year's earnings.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
VEEV Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Moderate | |
| High |
VEEV has the edge over HIMS on the outlook, with more favorable earnings expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
VEEV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.93 | +63% |
| Q3 2026 | $6.11 | +26% |
| Q2 2026 | $5.64 | +20% |
| Q1 2026 | $5.44 | +26% |
| Q4 2025 | $5.13 | +27% |
| Q3 2025 | $4.86 | +30% |
| Q2 2025 | $4.71 | +39% |
| Q1 2025 | $4.32 | +34% |
| Q4 2024 | $4.05 | +17% |
VEEV has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over VEEV on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
VEEV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $928M | +18% |
| Q2 2026 | $882.9M | +16% |
| Q1 2026 | $836M | +16% |
| Q4 2025 | $811.2M | +16% |
| Q3 2025 | $789.1M | +17% |
| Q2 2025 | $759M | +17% |
| Q1 2025 | $720.9M | +14% |
| Q4 2024 | $699.2M | +13% |
VEEV's revenue has grown year over year every quarter since late 2020: $928M last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | +4.8 points |
| Q2 2026 | 31% | +0.1 points |
| Q1 2026 | 29% | +3.3 points |
| Q4 2025 | 30% | +3.8 points |
| Q3 2025 | 25% | +0.2 points |
| Q2 2025 | 31% | +6.9 points |
| Q1 2025 | 26% | +4.7 points |
| Q4 2024 | 26% | +5.1 points |
VEEV has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS still generates free cash flow, though less than at its 2024 peak: $8M over the past year.
VEEV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $238.7M | +0.1% |
| Q2 2026 | $1.1B | +28% |
| Q1 2026 | $106.8M | +54% |
| Q4 2025 | $192.8M | +17% |
| Q3 2025 | $238.4M | +157% |
| Q2 2025 | $877.2M | +15% |
| Q1 2025 | $69.5M | +20% |
| Q4 2024 | $164.1M | +99% |
VEEV has the edge over HIMS on cash flow, with more consistent year-over-year improvement.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over VEEV on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
VEEV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -932K shares |
| 1 year | -1.6% | -2.6M shares |
| 3 years | +1.1% | +1.8M shares |
| 5 years | +1.4% | +2.3M shares |
| Available history | +4% | +6.3M shares |
VEEV has 165M diluted shares, down 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $245.7M |
| Q2 2026 | $226.9M |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
VEEV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2024 | -1.6x | Net Cash |
| Q4 2023 | -1.8x | Net Cash |
| Q3 2023 | -1.8x | Net Cash |
| Q2 2023 | -2.6x | Net Cash |
| Q1 2023 | -1.8x | Net Cash |
| Q4 2022 | -1.7x | Net Cash |
| Q3 2022 | -2.2x | Net Cash |
| Q2 2022 | -2.3x | Net Cash |
VEEV has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
VEEV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 66.5 | Neutral |
| Stochastic | 82.7 | Overbought |
VEEV's weekly RSI is 66 (neutral) and its Stochastic is 83 (overbought).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
VEEV PE vs Healthcare Sector
| Metric | VEEV | Sector median | Relative |
|---|---|---|---|
| PE | 50x | 26x | 91% above |
| PE % | 13 | 29 | 16 pts below |
VEEV is trading at 50x earnings, a 91% premium to the Healthcare sector's median of 26x.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
VEEV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $300.3 | 0.7% above |
| 20 week MA | $258.4 | 17% above |
| 50 week MA | $215.6 | 40% above |
| 100 week MA | $236.1 | 28% above |
| 200 week MA | $216.7 | 40% above |
VEEV has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
VEEV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $140.7 | $287.6 | +104% |
| 2021 | $287.6 | $260.6 | -9.4% |
| 2022 | $260.6 | $160.8 | -38% |
| 2023 | $160.8 | $192.5 | +20% |
| 2024 | $192.5 | $214.0 | +11% |
| 2025 | $214.0 | $224.7 | +5% |
| 2026 YTD | $224.7 | $302.4 | +35% |
VEEV has the edge over HIMS on returns for 2026, with the stronger performance.